bioAffinity Technologies BIAF
NASDAQ BIAF
$5.10 +0.02 (+0.39%)
As of: Aug 27, 2026 · 3:59 PM EDT

bioAffinity Technologies (BIAF) Total Non-Current Liabilities (2025)

bioAffinity Technologies (BIAF) posted quarterly Total Non-Current Liabilities of $2.9 million for Q2 2025.

bioAffinity Technologies (BIAF) Total Non-Current Liabilities (2025) Analysis & Trends

bioAffinity Technologies (BIAF) has reported Total Non-Current Liabilities for 1 consecutive years, with $2.9 million the latest figure, recorded in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 108.64 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 85.84 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 715.49 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 5.45 Bn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 22.94 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 542.10 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 6.36 Bn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 3.39 Bn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 9.19 Bn
10 bioAffinity Technologies 1.78 Mn -649,139.45 - -

Historic Data

Download Data
DateValue
Jun 30, 2025 2.91 Mn